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Aging is characterized by a decrease in genome integrity, impaired organmaintenance, and an increased risk
of cancer, which coincidewith clonal dominance of expandedmutant stem and progenitor cell populations in
aging tissues, such as the intestinal epithelium, the hematopoietic system, and the male germline. Here we
discuss possible explanations for age-associated increases in the initiation and/or progression of mutant
stem/progenitor clones and highlight the roles of stem cell quiescence, replication-associated DNA damage,
telomere shortening, epigenetic alterations, andmetabolic challenges as determinants of stem cell mutations
and clonal dominance in aging.Introduction
The incidence of tissue dysfunction, diseases, and many
types of cancer, including colorectal cancer (CRC) and
some types of leukemia, exponentially increases with age,
and aging represents the single biggest risk factor for most
cancers (Smith et al., 2009; Yancik, 2005). However, the rea-
sons for this aging-associated failure in tissue maintenance
and the increase in cancer are poorly understood. Without a
doubt, cancer is largely driven by genome dysfunction,
frequently exemplified by specific genetic alterations that
drive one or more specific cancer phenotypes (Hanahan and
Weinberg, 2011). Overwhelming evidence indicates that the
genesis and progression of cancer depend on accumulation
of genetic alterations. This evidence includes epidemiological
modeling data (Armitage and Doll, 1954), in vitro cell transfor-
mation studies (Hahn et al., 1999; Land et al., 1983), analysis
of hereditary cancer predisposition syndromes (Knudson,
1971), molecular pathology of cancer progression (Kinzler
and Vogelstein, 1996), and recent large-scale complete
sequencing of cancer exomes and genomes (Alexandrov
et al., 2013).
The decline in functional capacity and genetic integrity of
adult tissue stem cells is thought to be a major factor in the
decline in tissue maintenance and the increase in cancer for-
mation during aging (Behrens et al., 2014; Rando, 2006).
Linking the genetic and stem cell models of cancer, a recent
study proposed that the accumulation of mutations through
stem cell divisions is a major determinant of lifetime cancer
risk (Tomasetti and Vogelstein, 2015). However, this model
does not easily explain the exponential increase in cancer
incidence with age, nor the recently discovered exponential
increase in clonally expanded mutant stem cells in the male
germline, the hematopoietic system, and the intestinal epithe-
lium of aging humans (Busque et al., 2012; Genovese et al.,
2014; Jaiswal et al., 2014; Greaves et al., 2006; Hsieh et al.,
2013; Goriely and Wilkie, 2012).Clonal Dominance of Mutant Stem and Progenitor Cells
Increases Exponentially with Age
Recent studies on stem and progenitor cells have begun to shed
light on the exponential age-dependent increase in cancer. Ag-
ing is associated with an exponential increase in the occurrence
of clonal hematopoiesis, where a single mutant hematopoietic
stem or progenitor cell (HSPC) contributes to a significant,
measurable clonal proportion of mature blood lineages (Busque
et al., 2012; Genovese et al., 2014; Jacobs et al., 2012;
Jaiswal et al., 2014; Laurie et al., 2012; Shlush et al., 2014; Xie
et al., 2014). Evolution of mutant clonal hematopoiesis with age
predicts leukemia risk and the risk of other aging-associated dis-
eases (Genovese et al., 2014; Jaiswal et al., 2014; Shlush et al.,
2014). Of note, most of the mutations that result in clonal hema-
topoiesis in aging humans are leukemia related and recurrently
affect the same set of genes (Busque et al., 2012; Genovese
et al., 2014; Jaiswal et al., 2014; Shlush et al., 2014; Xie et al.,
2014). These data indicate that the mutations are non-neutral
and strongly selected for in aging. Mutant clones can acquire
additional mutations and the sequential evolution of clones
with multiple mutations was observed in primary, secondary,
and tertiary clones within the pre-malignant HSC compartment
of acute myeloid leukemia (AML) patients (Jan et al., 2012).
Deep-sequencing analysis of blood samples from large human
cohorts detected mutant, clonal hematopoiesis in a low fre-
quency (< 0.9%) of people below the age of 45 years. However,
above the age of 45 years the frequency of mutant, clonal hema-
topoiesis rises greatly, affecting 25%–70% of people at the age
of > 70 years, depending on the sensitivity of the method of
detection (Genovese et al., 2014; Jaiswal et al., 2014; McKerrell
et al., 2015).
Aging is also associatedwith clonal selection of aberrant intes-
tinal stemcells (ISCs). The ISCcompartment is divided into sepa-
rate crypt units, each containing 7–14 SCs. Neutral drifts within
each crypt lead to clonal dominance of single ISCs in about 3-
to 8-month time intervals in mice and in time intervals of up to 8Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 601
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2010; Snippert et al., 2010). Although the number of analyzed
individuals is low, clonal crypt-dominance of ISCs harboring
chromosomal gains and losses or mitochondrial DNA mutations
appears to accumulate during aging in the human intestinal
epithelium (Greaves et al., 2006; Hsieh et al., 2013).
Taken together, several observations argue that the clonal
expansion of mutant stem and progenitor cells does not follow
a strictly linear kinetic over an individual’s lifespan. Rather, the
clonal dominance of such mutations increases exponentially
during aging.
For example, studies on the male germline identified a set of
genetic diseases that display a significant parental age effect
(PAE), in which an increased prevalence of PAE disease is
observed in the offspring of older fathers (reviewed in Goriely
and Wilkie, 2012; Maher et al., 2014). Studies on PAE diseases
revealed that simple additive models of replication errors could
not explain the exponential increases in disease incidence in
offspring of older fathers. Instead, mutations in the Ras pathway
were identified as the cause of PAE diseases leading to ‘‘selfish’’
expansion of mutant spermatogonial stem cells and exponential
increases in the mutant clone size in the testis of aging men
compared to spermatogonial stem cells carrying neutral muta-
tions (Goriely and Wilkie, 2012). Whether aging itself promotes
the clonal dominance of non-neutral mutations in spermatogo-
nial stem cells remains to be addressed in experimental settings.
In the hematopoietic system, studies revealed age-associated
increases in the incidence of base-pair mutations in HSPCs. Of
note, some mutations are detectable early in life and show
rather linear increases with age, while others (e.g., mutations
in spliceosome factors) become detectable only late in life and
exhibit exponential increases with aging (McKerrell et al.,
2015). These data indicate that aging affects the clonal domi-
nance of stem/progenitor cell mutations but the effect size
appears to depend on cell intrinsic process, e.g., the type of
mutation and the affected pathways. In addition to base pair
mutations, there is evidence for an aging-associated increase
in clonal mosaicism originating from HSPCs with large chromo-
somal anomalies (deletions, duplications, and acquired uni-
parental disomies). In humans, such lesions are detectable at
a constantly low frequency of 0.2%–0.5% until the age of 50
years. Thereafter, this percentage rises rapidly to 2%–2.5% by
the age of 80 years (Jacobs et al., 2012; Laurie et al., 2012).
Similarly, twin studies revealed that mosaic anomalies were
undetectable at a young age but sharply increased in
pairs > 55 years old (Forsberg et al., 2012). Mosaic individuals
show an increased cancer risk and recurrent anomalies affect
important genes known to control incidence of hematopoietic
cancers, such as TET2 and DNMT3a (Jacobs et al., 2012; Laurie
et al., 2012). Together, these data suggest that cancer-
associated genetic alterations are present at detectable levels
in hematopoietic cells of some younger individuals but clonal
dominance of these alterations apparently increases expon-
entially during aging, presumably through selection for advan-
taged clones. In line with this interpretation, X-inactivation
markers in healthy women appear to be stable and do not
show clonal expansion during aging (Swierczek et al., 2008).
Presumably, such markers do not confer a selective advantage
on clones.602 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.Aging-associated increases in stem and progenitor cell muta-
tions can in principle be driven by increases in mutation initiation
rates and/or in the selection and clonal dominance of stem and
progenitor cells that have acquired non-neutral mutations. The
use of inducible in vivo lineage tracing is key to investigating
the influence of age on mutation initiation and clonal selection.
In themouse intestine, such approaches have allowed the detec-
tion and tracing of mutation initiation and clonal dominance of
labeled stemcells (Kozar et al., 2013;Ritsmaet al., 2014;Snippert
et al., 2010; Vermeulen et al., 2013). Continuous labeling
confirmed that the rate of initiation of neutral mutations (loss of
base pairs in a (CA)30 base pair-repeat tract leading to activation
of a marker gene) and the clonal dominance of such neutral mu-
tations does not change over the lifetime of mice (Kozar et al.,
2013; Taoet al., 1993,Wintonet al., 1988). Although thesestudies
on the intestine did not reveal an influence of age on the induction
of single-base-pair mutation per se, it should be noted that (1) the
induction rate of other types of mutations, e.g., large chromo-
somal abnormalities, may not be constant during lifetime (see
belowdiscussion on telomeres as a cause of chromosomal insta-
bility) and (2) aging-induced increases in base-pair mutation may
be restricted to specific tissue types (see below discussion on
aging-induced impairments in replication in hematopoietic stem
cells).
Inducible expression of a reporter, along with the induction of
colorectal cancer (CRC) driver mutations, revealed that some
CRC driver mutations (e.g., oncogenic Ras) promote clonal
dominance of mutant ISCs compared to competing wild-type
ISCs within the crypt under homeostatic conditions in young
mice (Vermeulen et al., 2013). However, these studies also
showed that bona fide CRC-driver mutations are often outcom-
peted by non-mutant ISCs. In addition, the clonal dominance of
CRC-driver mutations can be context dependent. For example,
deletion of p53 promoted clonal dominance of ISCs in the
context of intestinal inflammation but not in the non-inflamed in-
testine (Vermeulen et al., 2013). Together, these studies indicate
that clonal dominance of non-neutral (CRC driver) mutations
occurs in the intestinal epithelium and this can be context
dependent. The influence of the context of aging remains to be
delineated.
Overall, where there is available experimental evidence, e.g.,
in the intestinal epithelium, it invariably points to linearity in
de novo mutation rates with age. However, it was shown that
chronic low doses of exogenous genotoxic stress caused expo-
nential increases in mutation rates at the mouse Dbl1 gene in the
intestinal epithelium (Shaver-Walker et al., 1995). It remains to be
investigated whether aging-associated cell-intrinsic increases in
genotoxic stress, such as telomere shortening, replication
stress, and epigenetic alterations (see below), could changemu-
tation rates possibly in a tissue-specific manner. Along these
lines, studies on human genetic diseases of impaired telomere
maintenance revealed tissue specificity in regard to organ failure
and cancer initiation, both being more pronounced in the
hematopoietic system compared to the intestinal epithelium
(Calado and Young 2009). In addition, aging appears to influence
the kinetics of clonal selection of non-neutral, oncogenic muta-
tions in somatic stem and progenitor cell compartments. Both
processes—mutation initiation and their clonal selection—need
to be investigated in a tissue-specific manner employing animal
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Figure 1. Multiple Factors Conspire to Drive Age-Associated Cancer
Some congenital cancer-causing mutations are thought to be well-tolerated
by young cells and tissues. Other cancer-causing mutations are acquired
through aging. These congenital and acquired mutations conspire with other
more progressive events, e.g., telomere shortening, replication stress,
epigenetic and metabolic changes, to drive a dramatic increase in late-life
cancer. Open lollipops, unmethylated CpG; filled lollipop, methylated CpG;
yellow lightning bolt, genotoxic/mutagenic event.
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molecular mechanisms that may increase somatic mutations
during aging (Figure 1).
Stem Cell Quiescence: Preserving Genome Integrity of
Aging Stem Cells?
A small number of quiescent hematopoietic stem cells (HSCs)
stand at the top of the hierarchy of the hematopoietic system,
giving rise to all lineages of the peripheral blood. HSCs rarely
divide in the course of several months (Wilson et al., 2008).
This rarity of division of HSCs, also referred to as stem cell quies-
cence, has been shown to protect HSCs from accumulation
of molecular damage, including the induction of replication-
associated DNA damage, oxidative-stress-induced damages,
and telomere shortening (Walter et al., 2015, Rossi et al., 2007,
Choudhury et al., 2007) (Figure 2). There is evidence that the
functionality of HSCs decreases with each round of division
(Beerman et al., 2013) and aging-associated defects in DNA
replication may aggravate these processes (Flach et al., 2014).
Despite the evidence that quiescence protects HSCs from
DNA damage accumulation and functional decline, there
is also evidence that HSC quiescence promotes the accumula-
tion of DNA damage and mutations by allowing the survival
of damaged cells and error-prone repair (Mohrin et al., 2010,
Beerman et al., 2014). However, cell-cycle entry of damaged
HSCs promotes DNA repair or the removal of damaged HSCs
(Beerman et al., 2014, Wang et al., 2014, Walter et al., 2015).
Together, there is clear evidence that quiescence protects
HSCs from functional exhaustion, but the net effect of stem cell
quiescence on initiation and clonal dominance of DNAmutations
in the aging hematopoietic system remains to be studied in
greater detail. In addition, theprecise cell of origin for aging-asso-ciated, mutant, clonal hematopoiesis is not yet defined. Recent
studies in mice revealed that under homeostatic conditions
hematopoiesis is maintained predominantly by early hematopoi-
etic progenitor cells or short-term HSCs but does not require a
very active involvement of long-term HSCs (Busch et al., 2015;
Sun et al., 2014b). However, in response to stress, long-term
HSCs are activated to contribute to hemato-/lymphopoiesis
(Busch et al., 2015). Of course, it remains to be seen to what
extent hematopoietic homeostasis in laboratory mice kept under
pathogen- and stress-free conditions mimics the situation in
animals in the wild or in humans exposed to various types of
stress during life, including fasting, infections, weather extremes,
etc. Nevertheless, a significant contribution of progenitor cells
and short-term HSCs to clonal expansion of mutant hematopoi-
etic cells should not be excluded at this time, and future studies
need to better define the cell type of origin of initiation and clonal
dominance of mutant hematopoiesis. It should, however, be
noted that maintenance of quiescence could also be relevant
for mutation prevention at the early progenitor cell level, as there
is clear evidence that early hematopoietic progenitor cells main-
tain a higher level of quiescence than downstream progenitors
(Passegue´ et al., 2005). Accordingly, the maintenance of quies-
cence of stem and progenitor cells should be considered as an
important, yet to be experimentally proven, cellular mechanism
to prevent premature increases in DNA mutations leading to tis-
sue aging and cancer formation. Experiments on animal models
are required to determine candidate mechanisms that could
influence the rate of somatic mutations in a replication/quies-
cence-dependent manner. Candidate mechanisms that could
be involved include replication-associated errors and imperfect
repair resulting in base mutation, or inter-chromosomal rear-
rangement induced for example by chromosomal instability
and missegregation in response to replication-coupled telomere
dysfunction (see below). Tomasetti and Vogelstein recently
invoked replication-coupled stem cell mutations to explain the
strong relationship between lifetime cancer risk and number of
stem cell divisions across tissues (Tomasetti and Vogelstein,
2015). Extending this concept, there are many examples of
chronic diseases that cause increased rates of cell turnover in
the affected organs, which in turn associates with an increased
risk of early cancer development in those organs (see for example
connection between cirrhosis and liver cancer in chronic liver dis-
ease as reviewed in El-Serag and Rudolph, 2007).
Molecular mechanisms that control stem cell quiescence are
emerging (Maryanovich et al., 2012; Sirin et al., 2010; Tsai
et al., 2013; Walkley et al., 2005; Ye et al., 2013). Interestingly,
several factors critical for the maintenance of HSC quiescence
also influence health and lifespan. The transcription factor Nrf2,
for example, has an evolutionarily conserved role in regulating
stem cell quiescence, including of ISCs in Drosophila (Biteau
et al., 2011) and of HSCs in mice (Tsai et al., 2013). Nrf2 has
been implicated in the positive effect of calorie restriction on life-
span, which in mice is associated with a suppression of aging-
associated cancer formation (Pearson et al., 2008). Other factors
required for HSC quiescence include ATM, which has a known
role in protecting cells and tissues from premature aging by pro-
moting DNA repair and antioxidant defense (Maryanovich et al.,
2012), and CEBP/a (Ye et al., 2013). Furthermore, loss of p21-
dependent stem cell quiescence can lead to aging-associatedCell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 603
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in HSCs (Cheng et al., 2000; Kippin et al., 2005).
A direct link between the age-related loss of stem cell quies-
cence and decline of tissue function and associated increase
in mortality has been demonstrated in the intestinal epithelium
in Drosophila. In young animals, the ISC population is largely
quiescent but can be activated rapidly upon stress or tissue
damage (Amcheslavsky et al., 2009; Biteau et al., 2008, 2011;
Biteau et al., 2010; Buchon et al., 2009). The proliferative
response of ISCs to damage is transient, and a return to the
quiescent state after a regenerative episode is critical for tissue
homeostasis (Biteau et al., 2010; Buchon et al., 2009). In old
animals, this control of ISC proliferation is lost, resulting in
epithelial dysplasia. Excessive ISC proliferation in aging intes-
tines is caused by reactive oxygen species (ROS) that are pro-
duced by Dual Oxidase (Duox), an enzyme that generates an
oxidative burst to control commensal and pathogenic bacteria.
In old flies, Duox expression and activity is increased in the intes-
tinal epithelium due to immune dysfunction and commensal dys-
biosis (Biteau et al., 2008, 2010; Buchon et al., 2009; Guo et al.,
2014). Promoting stem cell quiescence through various interven-
tions, such as reducing stress-activated signaling pathways,
improving immune homeostasis, limiting commensal dysbiosis,
or reducing ISC proliferation directly, is sufficient to improve tis-
sue homeostasis in the intestinal epithelium of old flies and
extend lifespan (Biteau et al., 2010; Guo et al., 2014). While these
studies highlight the importance of stem cell quiescence for tis-
sue maintenance, it remains unclear whether age-related over-
proliferation of Drosophila ISCs is associated with increased
genomic alterations. However, lineage tracing has revealed
defects in differentiation capacity of old ISCs, suggesting
changes not only in activity, but also in functionality of these cells
(Biteau et al., 2008). Whether these changes are driven by accu-
mulatedmutations, epigenetic changes, or extrinsic influences in
the aging tissue remains to be established.
In contrast to the ISC system inDrosophila, themouse intestine
is maintained by highly proliferative LGR5+ ISCs dividing at
approximately 24-hr intervals (Barker et al., 2007). Each intestinal
basal crypt contains 7–14 ISCs competing against each other for
self-renewal (de Navascue´s et al., 2012; Kozar et al., 2013; Snip-
pert et al., 2010). A critical determinant of competitive advantage
is the position of each ISC relative to theWnt3-producing Paneth
cells (see above, for review Clevers, 2013). In this population of
highly proliferative ISCs, the maintenance of quiescence is likely
not an important factor for maintenance of self-renewal, nor for
preventing initiation and/or clonal dominance of mutations in
these stem cells during aging. Interestingly, it was shown that
the level of Wnt-signaling activity depending on the positioning
of ISCs in the stem cell niche influences the survival of ISCs in
the context of DNA damage. ISCswith lowWnt-activity preferen-
tially survive compared to ISCswith highWnt-activity in response
to both telomere shortening and irradiation-induced DNA dam-
age (Tao et al., 2015). These data suggest that niche positioning
andWnt-activity could influence thecell typeof origin and the rate
of mutation initiation in the context of DNA damage. In sum, it is
likely that tissue context and differences in the stem cell biology
across different tissues and species influence the requirement
for stemcell quiescence for suppression ofDNAdamage, genetic
mutations, and maintenance of stem cell function.604 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.Telomere Shortening Initiates Clonal Drift in Stem Cell
Pools and Clonal Dominance of Mutant Stem Cells
Telomere shortening is a well-defined mechanism underpinning
cell mortality, which could also contribute to exponential
increases in genomic instability of adult cells in response to repli-
cative aging, when critical telomere shortening leads to telomere
uncapping and the induction of genomic instability. Studies from
yeast to mammals provided experimental evidence for this inter-
relationship (Begus-Nahrmann et al., 2009; Hackett and Greider,
2003; Rudolph et al., 2001, Seluanov et al., 2004). Telomeres
shorten in almost all human tissues during aging, including
HSPCs (Vaziri et al., 1994) and the intestinal epithelium (Hiyama
et al., 1996). These data indicate that telomerase activity—
although required to ensure the long replicative lifespan of
stem and progenitor cells (Holohan et al., 2014; Rudolph et al.,
1999) —apparently is not sufficient to prevent age-associated
shortening of telomeres in stem and progenitor cells. Moreover,
accelerated shortening of telomeres in stem cell compartments
of the intestinal epithelium and the hematopoietic system occurs
in the context of chronic diseases and is linked to evolution of
chromosomal instability, tissue dysfunction, and an increased
cancer risk in humans (Risques et al., 2008; Townsley et al.,
2014; Wang et al., 2012).
Telomere shortening may enhance initiation and evolution of
clonal dominance of mutant stem cells during tissue aging
(Figure 2). Critically short telomeres induce chromosomal insta-
bility and loss of heterozygosity in yeast (Hackett and Greider,
2003). Studies on telomerase-deficient mice revealed that, in
the intestinal epithelium, telomere dysfunction induces clonal
dominance of chromosomal unstable ISCs, albeit only in the
context of p53 deficiency (Begus-Nahrmann et al., 2009). Of
note, the increase in clonal dominance of chromosomal unstable
ISCs resulted in accelerated tissue dysfunction and lifespan
shortening of the mice, thus providing a proof of concept that
stem cell mutations not only contribute to cancer development
but can also aggravate aging-associated tissue dysfunction (Be-
gus-Nahrmann et al., 2009).
In the hematopoietic system, telomere dysfunction acceler-
ated aging-associated drifts within the pool of HSCs (Wang
et al., 2012) (Figure 2). Typically, aging is characterized by a
dominance of myeloid-biased HSPCs, preferentially differenti-
ating into the myeloid lineage, and a paucity in lymphoid-biased
HSPCs, preferentially differentiating into the lymphoid lineage
(Ju et al., 2007; Wang et al., 2012). Studies showed that telomere
dysfunction induced alteration in the stem cell environment, as
well as a DNA-damage-dependent, differentiation-inducing
checkpoint that promoted the preferential loss of self-renewing
lymphoid-biased HSCs (Ju et al., 2007; Wang et al., 2012).
Together, studies in telomerase-deficient mice provided
experimental evidence that telomere dysfunction promotes
clonal drifts in the pool of tissue stem cells, as well the initiation
and clonal dominance of mutant stem cells with large chromo-
somal abnormalities (Figure 2). The prevalence of telomere
shortening in aging human tissues also suggests that telomere
dysfunction could contribute to the observed increases in clonal
dominance of chromosomal unstable stem cells in human intes-
tinal epithelium (Hsieh et al., 2013) and the hematopoietic system
(Jacobs et al., 2012; Laurie et al., 2012) in the context of aging.
Despite experimental evidence on the role of telomere
Figure 2. Aging-Induced Initiation and Clonal Selection of Stem and
Progenitor Cell Mutations
Aging-associated alterations that could contribute to the exponential increase
in the initiation of DNA damage, mutations, and large chromosomal aberra-
tions include telomere shortening and the dysregulation of components that
control chromosome segregation, DNA replication, or DNA repair. There is
evidence that cell division rates and metabolic activity induce these alter-
ations, whereas stem and progenitor cell quiescence can prevent it. Genomic
damages induce checkpoint responses, epigenetic alterations, and metabolic
shifts that decrease the fitness of the damaged cells. These responses
represent a double-edged sword. In young tissues, these responses are tumor
protective by inhibiting the survival or the clonal expansion of single, individual
stem and progenitor cells that acquire mutations or chromosomal aberrations.
In contrast, the same responses can also limit the self-renewal and prolifera-
tive capacity of a growing number of normal stem and progenitor cells in aging
tissues, which in turn promotes decreases in clone number, clonal drifts, and
clonal dominance of mutant stem cells. Accordingly, the downregulation of
damage responses/checkpoints is positively selected for both in the pool of
aging stem and progenitor cells as well as in individual stem cells that acquire
mutations or chromosomal aberrations. Red boxes define processes that
contribute to the initiation and/or clonal dominance of mutant stem and pro-
genitor cells, whereas processes depicted in blue boxes impair it. Epigenetic
alterations, damage checkpoints, and metabolic alterations in response DNA
damage and mutations have a dual role by affecting both the fitness of normal
stem and progenitor cells as well as of mutants.
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that there is an apparent lack of knowledge on the role of telo-
mere shortening in promoting the initiation of gene mutations
in stem and progenitor cell compartments in aging mammals.
Interestingly, it was recently shown that telomere dysfunction
induces defects inmRNA splicing by suppressing the expression
of SRSF2 (Colla et al., 2015), which represents one of the genes
affected bymutations that exhibit a strong positive selection dur-
ing human aging (McKerrell et al., 2015). These data suggest that
telomere shortening in the hematopoietic system promotes the
clonal dominance of aging-associated stem and progenitor cell
mutations.
In addition to telomere shortening, molecular components that
regulate chromosome segregation, such as BubR1, influence
tissue aging. Genetic experiments in mice showed that the
downregulation of BubR1 induces aneuploidy and premature
aging (Baker et al., 2004), whereas increases in BubR1 expres-
sion extended the tissue maintenance, health, and lifespan
(Baker et al., 2013; North et al., 2014). Of note, BubR1 exhibits
a significant downregulation in several tissues during aging(Baker et al., 2004) and alterations in the expression of mitotic
genes appeared as a characteristic feature of human aging (Ly
et al., 2000). It is conceivable that these alterations affect the
functionality of both stem and progenitor cells (Figure 2). The
impact of aging-associated alterations in the expression of
mitosis/chromosome-regulating genes on initiation and clonal
dominance of stem and progenitor cell mutations remains to
be investigated, given the evidence that failures in chromosome
segregation can induce loss of heterozygosity and cancer forma-
tion (for review see Ricke et al., 2008).
Replication Stress Increases in Aging Stem Cells
Suppression of replication stress likely contributes to the protec-
tive effects of quiescence to counter age-dependent accumula-
tion of genetic alterations. Emerging data indicate that DNA repli-
cation stress represents a molecular mechanism contributing to
the exponential increase in genome aberrations in populations of
aging stem cells (Flach et al., 2014; Walter et al., 2015). Despite
their quiescence (see previous section), aged HSCs acquire a
problem in DNA replication due to an aging-associated decrease
in the expression of mini-chromosome maintenance (MCM) heli-
case components (Flach et al., 2014). This defect appears not to
disturb hematopoiesis under homeostatic conditions, but sup-
presses the functionality of aged HSCs in response to hemato-
poietic stress. Of note, it was shown that replication stress and
DNA damage are triggered by a burst of oxidative stress when
quiescent HSCs are stimulated to enter the cell cycle in response
to physiological stimuli, such as blood loss or infection-induced
stimuli, such as interferon signaling (Walter et al., 2015). HSC
replication stress in response to such stimuli led to severe
bone marrow failure in mice with a deficient Fanconia anemia
(FA) repair pathway, thus suggesting a resolution to the paradox
whereby the FA pathway-deficient mouse models show no
severe defects in hematopoiesis under homeostatic conditions
but FA patients suffer from severe anemia and bone marrow fail-
ure. Whether impairments in DNA replication in response to
aging contribute to an increased frequency of DNA mutations
in normal aging mice and humans remains to be investigated
(Figure 2). However, these data indicate that experimental condi-
tions thatmimic ‘‘physiological’’ replication stress of the hemato-
poietic system are relevant for modeling hematopoietic diseases
and aging in humans, whichmay not bemodeled by homeostatic
hematopoiesis in laboratory mice housed under stress-free con-
ditions. This should be considered when exploring the role of
DNA replication stress in driving the acquisition and clonal domi-
nance of mutant HSCs in aging.
Replication stress was recently shown to have dual antago-
nistic roles in suppression and initiation of CIN/aneuploidy
depending on the functionality of checkpoints. Replication stress
is induced in response to aneuploidy and CIN in primary human
cells and in human cancer cells (Burrell et al., 2013; Meena et al.,
2015). In primary human cells with intact checkpoints, aneu-
ploidy induces replication stress at telomeres, which in turn
leads to aneuploidy-induced senescence suppressing the prolif-
erative capacity of aneuploid cells (Meena et al., 2015). Of
note, endogenous expression of telomerase in murine HSCs
was sufficient to alleviate aneuploidy-induced replication stress
at telomeres and aneuploidy-induced senescence. These data
suggest that telomerase suppression in somatic cells mayCell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 605
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Figure 3. Age-Associated Chromatin Changes Exhibit Diverse
Mechanisms, Functions, and Dysfunctions
Some age-associated chromatin changes are tumor-suppressive pro-
grammed responses in stressed or damaged cells (left). Others are pseudo-
programmed and in principle could be oncogenic (middle), tumor suppressive
(not shown), or neutral (not shown). For example, bivalent gene promoters
marked with H3K4me3 and H3K27me3 persist from ES cells into adult stem
cells and facilitate developmental transitions. However, in adult tissues,
bivalent promoters are, perhaps inadvertently, DNA methylated and silenced,
thereby blocking differentiation. By this model, bivalent promoters are
antagonistic pleiotropic—they facilitate developmental transitions in ES cells
and young stem cells but can be precursors to self-renewing, non-differenti-
ated cancer stem cells in old tissues. Other age-associated chromatin
changes reflect epigenetic drift or failed chromostasis of the dynamic epi-
genome (right). Such drift is not inherently oncogenic or tumor suppressive but
leads to stochastic epigenetic mosaicism and cell-to-cell variation, which can
be a substrate for clonal selection of neoplastic cells.
Cell Stem Cell
Reviewprevent the propagation of whole chromosomal gains and losses
by promoting replication stress at telomeres in response to
aneuploidy and, hence, aneuploidy-induced senescence. While
telomerase is clearly required to ensure the replicative potential
and to suppress telomere dysfunction-induced CIN of aging
stem and progenitor cells, this also appears to increase the
risk of these cells to accumulate aneuploidy.
In contrast to primary cells with intact checkpoints, the induc-
tion of replication stress in response to CIN was shown to aggra-
vate the CIN-phenotype in checkpoint-deficient, human cancer
cells (Burrell et al., 2013). These data indicate that the initiation
and clonal dominance of chromosomal unstable cells may
depend on both the telomerase expression status and the func-
tionality of DNA damage checkpoints. Of note, studies on
g-irradiated mice revealed a significant aging-associated blunt-
ing in the induction of p53 checkpoint activity in hematopoietic
tissues (Feng et al., 2007). Together it is possible that endoge-
nous expression of telomerase in stem cells coupled with
aging-associated defects in DNA damage checkpoints and
increase in replication stress promote the emergence of chromo-
somal unstable stem and progenitor cell clones characteristic of
human aging (Hsieh et al., 2013; Jacobs et al., 2012; Laurie et al.,
2012). Despite the evidence for a decrease in DNA damage
checkpoint fidelity in aging tissues, mutations of p53 and RB
are frequently found in mutant clonal hematopoiesis associated
with aging (Laurie et al., 2012; Xie et al., 2014). These data indi-
cate that the loss of these checkpoint genes is positively606 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.selected for in aging clonal hematopoiesis, possibly triggered
by impaired HSC function induced by replication stress, telo-
mere shortening, or other types of DNA damage (Figure 2).
In addition to its antagonistic role in protection/induction of
large chromosomal aberrations, it is possible that replication
stress would also influence the initiation and/or clonal do-
minance of base-pair mutations in aging stem and progenitor
cells (Figure 2). This shift could further be promoted by aging-
associated defects in components of DNA repair pathways
(Figure 2). There is some evidence that efficiency of non-
homologous end joining DNA repair decreases in human fibro-
blasts entering the stage of replicative senescence in culture
(Seluanov et al., 2004). Whether aging-associated repair defi-
ciencies occur in stem and progenitor cells in vivo remains to
be addressed experimentally.
Epigenetic Alterations Could Influence Clonal
Dominance of Non-neutral Stem and Progenitor Cell
Mutations
Aging is also associated with changes to the epigenome. Key
early reports showed this in various tissues, including intestine
and white blood cells (Berdasco and Esteller, 2012). In the intes-
tine, this has been confirmed at the level of individual intestinal
crypts (Kim et al., 2005). More recently, comprehensive studies
of mouse HSCs also showed changes in DNA methylation with
age, including a small net hypermethylation both globally and
at CpG islands during normal aging, and a more pronounced
global hypomethylation when additional excessive proliferation
is enforced through transplantation (Beerman et al., 2013; Sun
et al., 2014a). Underscoring the importance of epigenetic control
of aging, several reports have functionally linked epigenetic con-
trol to aging and longevity (Dang et al., 2009; Greer et al., 2010).
Analyses of stem cells have begun to define age-associated
changes that might underlie age-associated stem cell dysfunc-
tion. For example, a comparison of muscle stem cells from
young and old mice showed that old stem cells exhibit elevated
repressive H3K27me3 at repressed histone genes (Liu et al.,
2013) and a de-repression of the epigenetic regulated cell-cycle
inhibitor and senescence inducer p16/Ink4a (Sousa-Victor et al.,
2014). The former may be a consequence of decreased prolifer-
ative potential of these aged stem cells (Marzluff et al., 2008) but
is also expected to reinforce and exacerbate degenerative
age-associated chromatin changes by restricting homeostatic
nucleosome dynamics, so-called ‘‘chromostasis’’ (Rai et al.,
2014). AgedmouseHSCs accumulate DNAmethylation changes
expected to promote expression of self-renewal genes and
impair expression of differentiation genes, including lymphoid
genes, likely contributing to the reported corresponding pheno-
types in aged HSCs (Sun et al., 2014a). Underscoring the impor-
tance of such age-associated epigenetic changes, recent
human studies have identified relatively small numbers of
CpGs whose age-associated change in methylation status in
multiple tissues correlates strongly with chronological age and
biological age, the latter linked to predisposition to disease
and mortality (Hannum et al., 2013; Horvath, 2013; Marioni
et al., 2015; Weidner et al., 2014).
Some age-associated epigenetic changes likely act as bar-
riers to cell transformation and cancer (Figure 3). For example,
histone modification H4K20me3 increases in aged tissues and
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and Esteller, 2012). Conversely, downregulation of H3K27me3 in
aged pancreas is linked to derepression of tumor suppressor
p16INK4a (Dhawan et al., 2009), and some cancers exhibit
elevated H3K27me3 (Morgan and Shilatifard, 2015). Premature
aged Hutchinson Gilford progeria cells are resistant to transfor-
mation, in part due to enhanced Brd4-mediated inhibition of
oncogene-driven de-differentiation, linked to altered epigenetic
programming (Fernandez et al., 2014). Such changes likely
reflect programmed chromatin-mediated tumor suppressor
mechanisms that are activated in stressed and/or aged cells.
Other age-associated chromatin changes likely promote can-
cer. Some such chromatin changes are, perhaps, best viewed as
a form of epigenetic damage, in part due to stochastic drift of a
dynamic epigenome (Figure 3). For example, like cancer, tissue
aging has been reported to be associated with global DNA hypo-
methylation and more focal hypermethylation at CpG islands
(Berdasco and Esteller, 2012). Similar results have been reported
in senescent cells in culture (Cruickshanks et al., 2013). CpG
islands methylated in aging and senescence include islands
hypermethylated in cancer and thought to contribute to gene
silencing (Berdasco and Esteller, 2012, Cruickshanks et al.,
2013). In the hematopoietic system, some CpG islands show
progressively increased methylation from young, to old, to mye-
lodysplastic syndrome (MDS), and ultimately to AML (Maegawa
et al., 2014). As well as acquiring epigenetic changes linked
to increased self-renewal and decreased differentiation (see
above), aged HSCs also display such hypermethylation events
characteristic of MDS. Most notably, the gene Sf3b1, the human
ortholog of which ismutated in about 20%ofMDS, is methylated
and underexpressed in agedmouse HSCs (Sun et al., 2014a). By
contributing to silencing of such tumor suppressor genes, such
age-associated methylation changes might predispose to can-
cer in aged cells. Poorly defined chromostatic mechanisms likely
retard the development of such deleterious age-associated
changes.
Paradoxically, however, some of these age-associated can-
didate oncogenic epigenetic changes might be pseudo-
programmed within the epigenome itself (Figure 3). So-called
bivalent genesmarkedwith H3K4me3 andH3K27me3 in ES cells
tend to be DNA methylated in aged tissues and methylated and
silenced in cancer (Ohm et al., 2007; Rakyan et al., 2010; Schle-
singer et al., 2007; Teschendorff et al., 2010; Widschwendter
et al., 2007). Some adult stem cells, including hair follicle stem
cells, muscle stem cells, andHSCs, also contain bivalentmarked
genes (Lien et al., 2011; Liu et al., 2013; Sun et al., 2014a). The
polycomb (PRC) complex is responsible for deposition of
H3K27me3, and, in HSCs, PRC target genes often succumb to
age-related DNA methylation (Sun et al., 2014a). Rossi and co-
workers proposed that, at least in some cases, DNA methylation
results from downregulation of PRC complexes that otherwise
antagonize DNA methylation (Beerman et al., 2013). Regardless
of the mechanism, an epigenetic signature linked to bivalency in
ES cells appears to track through adult stem cell populations and
is, perhaps inadvertently, predisposed to methylation and stable
gene silencing in aged cells. By this model, bivalent chromatin
can be considered to be antagonistic pleiotropic (Williams,
1957)—advantageous in ES cells and young adult stem cells,
but disadvantageous in old adult stem cells.Cancer-causing genetic mutations in epigenetic regulators
have been revealing regarding the tumor-suppressive functions
of the normal epigenome and possible tumor-promoting roles
of an altered aged epigenome. Mutations in epigenetic regula-
tors, for example DNMT3a, TET2, and ASXL1, are frequently
found in myeloid neoplasia (Shih et al., 2012). In a clutch of sem-
inal papers, mutations in these epigenetic regulators have been
revealed as the earliest genetic changes in the neoplastic pro-
gression. Thesemutations are associatedwith clonal dominance
of HSCs that are, at least in the case of those harboring hypo-
morphic DNMT3a mutations, phenotypically normal, albeit at
increased risk of myeloid malignancy (Corces-Zimmerman
et al., 2014; Genovese et al., 2014; Jaiswal et al., 2014; Jan
et al., 2012; Shlush et al., 2014; Xie et al., 2014). In mice, biallelic
knockout of DNMT3a confers increased self-renewal and
impaired differentiation of HSCs and predisposition to hemato-
logic neoplasia, including MDS and AML (Mayle et al., 2015). In
part, this reflects a role for DNMT3a in methylation and associ-
ated silencing of self-renewal genes, including Runx1 and
b-catenin (Challen et al., 2012, 2014). However, inactivation of
DNMT3a triggers other, apparently secondary, epigenetic
changes, including DNMT3b-mediated hypermethylation and
gene repression, and changes in histone modifications also
linked to gene repression (Challen et al., 2012, 2014). Conceiv-
ably, as well as contributing to a programmed pro-differentia-
tion/anti-self-renewal tumor suppressor function, DNMT3a
might also promote chromostasis to restrict more stochastic
epigenetic variation and plasticity in HSCs. While not directly
tumor promoting, increased cell-to-cell variation and mosaicism
resulting from inactivation of DNMT3a might be a substrate for
clonal selection of rare pre-neoplastic cells (Figure 3). Some sim-
ilarities in epigenetic changes due to DNMT3a inactivation and
aging, for example in DNA methylation poor ‘‘canyons’’ (Challen
et al., 2014; Sun et al., 2014a), suggest that inactivation of
DNMT3a might, to some extent, accelerate the epigenetic drift
and HSC mosaicism associated with normal aging and resultant
predisposition to myeloid neoplasia. In turn, such epigenetic
changes are likely to influence the selection for and against other
genetic mutations, the response to replication stress and
dysfunctional telomeres.
Metabolism Influences Aging and Functionality of Stem
Cells
Metabolism and signaling pathways that influence metabolism
are major determinants of the rate of aging and longevity and
also impinge on cancer. Studies in the nematodeC. elegans pro-
vided the first experimental evidence that the reduction of Insu-
lin-IGF1 signaling (IIS) increases lifespan (Kimura et al., 1997;
Kenyon et al., 1992). Improvements in healthspan have since
been demonstrated in response to dietary, small molecule, and
genetic interventions in metabolism and associated signaling
pathways (including IIS, mTORC1, and AMPK signaling) in
some strains of laboratory mice and non-human primates (Ken-
yon, 2010). Genetic studies on centenarians further imply a role
of the IIS pathway on longevity in humans (Flachsbart et al.,
2009; Willcox et al., 2008). Importantly, metabolic interventions
that increase longevity in mice tend to reduce the incidence of
cancer (Serrano and Blasco, 2007). For example, inhibition of
mTORC1 extends healthspan and longevity (Harrison et al.,Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 607
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also suppresses intestinal tumor initiation and progression in
APC deficient mice (Faller et al., 2015). mTORC1 inhibition ben-
efits the maintenance of ISC function, either through non-
autonomous effects from niche (Paneth) cells as described in
the mouse intestine (Yilmaz et al., 2012), or through cell-autono-
mous prevention of ISC differentiation in the fly intestine (Kapuria
et al., 2012).
However, the effects of these pathways are complex and
diverse, and the mechanisms underlying the tumor-suppressive
effects of reduced IIS and other metabolic signals remain to be
determined. Studies on calorie restriction and fasting-mediated
reduction in IIS revealed beneficial effects for the maintenance
of stem cell function under homeostatic conditions and in
response to stress (Cerletti et al., 2012;Cheng et al., 2014).More-
over, protective metabolic pathways (such as autophagy) were
induced and required for stem cell maintenance in response to
calorie restriction and may contribute to an improved clearance
of damaged molecules and cells in the pool of aging stem cells
(Warr et al., 2013). Long-term effects of such interventions on
stem cell function remain yet to be investigated.
It is also conceivable that some of the beneficial effects of
metabolic interventions involve suppression of cell-cycle activity
of stem cells. Increased stem cell quiescence in response to
such interventions may in turn delay the accumulation of
aging-associated mutations and/or the clonal dominance of
mutant stem cells in aging tissues (see above discussion on
stem cell quiescence, replication stress, and tissue aging).
Indeed, in the fly intestinal epithelium, ISC proliferation is regu-
lated by both local and systemic insulin-like peptides (Amche-
slavsky et al., 2009; Biteau et al., 2010; O’Brien et al., 2011),
and modulating insulin signaling activity as well as target genes
of Foxo is sufficient to limit over-proliferation of ISCs, promote
tissue homeostasis, and extend lifespan (Biteau et al., 2010).
Similarly, ISC homeostasis can bemaintained by overexpressing
the mitochondrial regulator PGC1a in ISCs specifically, resulting
in increased tissue integrity in aging flies and extending lifespan
(Rera et al., 2011).
In contrast to the beneficial effects of lowering IIS-signaling on
aging, there is emerging evidence that metabolic pathways
change in aging cells and tissues. Telomere dysfunction was
shown to trigger metabolic changes, including impaired mito-
chondrial biogenesis, which was shown to aggravate defects
on stem cell function and organ maintenance during aging
(Missios et al., 2014; Passos et al., 2010; Sahin and DePinho,
2012). Mitochondrial dysfunction is among the best-investigated
metabolic alterations that occur during aging in various tissues
(Bratic and Larsson, 2013). Mutations in mitochondrial DNA
can aggravate SC and tissue aging in mice (Kujoth et al., 2005;
Norddahl et al., 2011; Trifunovic et al., 2004). In addition, there
is emerging evidence that oncogene-induced senescence can
increase the rate of glucose metabolism both in glycolytic and
in oxidative pathways (Do¨rr et al., 2013; Kaplon et al., 2013). If
transferrable to telomere dysfunction-induced senescence and
tissue aging, increases in energy demand may occur in aging,
possibly requiring a different diet at advanced ages as compared
to adulthood. Along these lines, Igf1 and glucose application
exhibited beneficial effects on tissue maintenance in mouse
models of premature aging (Marin˜o et al., 2010; Missios et al.,608 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.2014). Regardless of the specific mechanisms and pathways,
age-dependent metabolic shifts might influence mutation fre-
quency, progression to clonal dominance, and cancer.
Outlook
There is emerging evidence that aging induces changes in
molecular pathways that accelerate the initiation and/or clonal
dominance of mutations in stem and progenitor cells. The tight
connection between aging-associated accumulation of stem
and progenitor cell mutations with the failure of tissue mainte-
nance and cancer suppression indicates a causal relationship
between these factors. In addition to the cell-intrinsic mecha-
nisms discussed here, there is increasing evidence that cell-
extrinsic factors affect stem cell maintenance and possibly the
selection of mutant stem and progenitor cells during aging.
Likely, and potentially exciting, extrinsic candidates include
aging-associated defects in the stem cell niches (Vas et al.,
2012), alterations in the systemic/blood circulatory environment
(Ju et al., 2007), changes in proliferative competition among
stem and progenitor cells (Bilousova et al., 2005; Henry et al.,
2010), inflammatory responses (Velarde et al., 2013), and defects
in immune surveillance of damaged cells (Kang et al., 2011). The
delineation of this interplay of cellular and molecular mecha-
nisms that contribute to the initiation and selection of stem and
progenitor cell mutations in the context of aging will undoubtedly
help the development of therapies aiming to improve early
detection, prevention, and risk assessment of aging-associated
diseases, organ dysfunction, and cancer.
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